CBS: Questions remain about COVID-19 booster shots

While federal officials continue to analyze the need for the general public to receive a third dose of the currently available mRNA COVID-19 vaccines, certain immunocompromised groups are already eligible for a booster shot.

Dr. Trisha Wise-Draper, medical director of the UC Cancer Center's Clinical Trial Office and UC associate professor of medicine in the Division of Hematology/Oncology, said research has shown cancer patients in particular should receive a third dose as soon as possible.

"Certain cancer patients, especially those with blood disorders, are more at risk of not developing antibodies to the vaccine and remain vulnerable to the infection,” Wise-Draper told Local 12 News, in a story that was picked up nationally by news affiliates. "[Many patients] are at exceedingly high risk of serious disease and mortality from COVID-19."

Watch the full Local 12 report.

Featured photo at top: Shutterstock.com